Franck Verdonk

Franck Verdonk is currently the Chief Medical Officer at Surge2Surgery. Prior to this, they worked as an interne in medicine at APHM from September 2017 to November 2021. Franck also worked as a medical student at CHU de Toulouse from September 2011 to November 2017.

Franck Verdonk first studied immunology at Stanford University. Franck then pursued a Master 2 in Medicine at Université Paul Sabatier Toulouse III and Toulouse Purpan Medical school. Franck obtained their Docteur en médecine from Aix-Marseille Université. Finally, they completed a Master 2 in Metabolic and Vascular Pathologies at Aix-Marseille Université. Franck is also certified C1 english level (CLES 3).

Some of their coworkers include Valentin Picot - Chief Operating Officer & General Counsel, Benjamin Choisy - Chief Product Manager, and Dyani Jones - Co-Founder & Prehab Growth Advisor. Franck Verdonk reports to Julien Hedou, Chief Executive Officer.